Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05602454 · ClinicalTrials.gov registry record · NA
Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)
A NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
- 7
- Study locations
NCT05602454: Completed NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Duke University.
NCT05602454 is a NA study of Heart Failure With Reduced Ejection Fraction that has completed, run by Duke University. The registered enrollment target is 178 participants, below the 3,959-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05602454, a NA study of Heart Failure With Reduced Ejection Fraction, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction
Primary Outcome
Scores are 0-3 for 7 key medication classes for heart failure with reduced ejection fraction where 0 represents no use of the medication class
Conditions Studied
Interventions
- OTHER Digital Heart Failure Medication Titration
Study Locations (7)
Florida
- Cardiovascular Institute of Northwest Florida - Panama City
Indiana
- Ascension St. Vincent - Indianapolis
Kansas
- The University of Kansas Medical Center - Kansas City
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
Missouri
- Saint Luke's Health Systems - Kansas City
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2025-03-05 |
| Phase | NA |
What the finished NCT05602454 record still lists
NCT05602454 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 3,959-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Digital Heart Failure Medication Titration is the first listed.
NCT05602454 lists 7 locations in 7 states (Florida, Indiana, Kansas).
Frequently Asked Questions
What is clinical trial NCT05602454 about?
NCT05602454 is a clinical study titled "Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)". The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction
What is the current status of trial NCT05602454?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2022-12-02. Estimated completion is 2025-03-05.
What conditions does trial NCT05602454 study?
This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.
What interventions are being tested in trial NCT05602454?
The interventions under investigation include: Digital Heart Failure Medication Titration (OTHER).
Who is sponsoring clinical trial NCT05602454?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05602454 being conducted?
This trial has 7 study locations across Florida, Indiana, Kansas, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Reduced Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05602454's enrollment target sits among peer trials
178 14th of 27 higher than 14 of 27 other Heart Failure With Reduced Ejection Fraction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure With Reduced Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
RECRUITING · NA
-
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
RECRUITING · NA
-
Home-Based Cardiac Rehabilitation for Patients With Heart Failure
RECRUITING · NA
-
The CardioClip Study
RECRUITING · NA
-
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI